NCT05523154View on ClinicalTrials.gov

"Answers in Hours A Randomized Controlled Trial Using Microbiome Metagenomics for Bile Duct Cultures"

NATerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 19, 2023

Primary Completion Date

September 12, 2023

Study Completion Date

November 27, 2023

Conditions
Benign Pancreatic NeoplasmMalignant Pancreatic Neoplasm
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of bile samples

OTHER

Laboratory Procedure

Undergo routine laboratory testing

DEVICE

Nanopore Sequencing

Undergo nanopore sequencing

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05523154 - "Answers in Hours A Randomized Controlled Trial Using Microbiome Metagenomics for Bile Duct Cultures" | Biotech Hunter | Biotech Hunter